Početna › Rak prostate › Montana
Kliničke studije za Rak prostate u državi Montana
17 studija za Rak prostate traži sudionike na lokacijama u državi Montana.
Gradovi u državi Montana
Službeni tekst studije (engleski)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Saint Vincent Frontier Cancer Center, Billings
- i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 2. lis 2026. · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- Benefis Sletten Cancer Institute, Great Falls
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 2. lis 2026. · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- i još 7
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Billings Clinic Cancer Center, Billings
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- i još 3
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT03866382A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06136650A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 17. ruj 2026. · NCT06925737Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Billings Clinic Cancer Center, Billings
- Benefis Sletten Cancer Institute, Great Falls
- Hi-Line Sletten Cancer Center, Havre
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 10. ruj 2026. · NCT05946213Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- Benefis Sletten Cancer Institute, Great Falls
- i još 5
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 19. kol 2026. · NCT04423211Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- i još 7
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 14. srp 2026. · NCT06592924Integrated Cancer Repository for Cancer Research
- Bozeman Health Deaconess Hospital, Bozeman
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- Billings Clinic Cancer Center, Billings
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 14. tra 2026. · NCT06235697Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
- University of Montana, Missoula
U tijeku regrutacijaFaza 2
Od 18 do 89 godina · Oba spola · Ažurirano 5. velj 2026. · NCT07001241Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Deaconess Hospital, Bozeman
- i još 4
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 29. sij 2026. · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 22. sij 2026. · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Billings
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Billings Clinic Cancer Center, Billings
- Bozeman Deaconess Hospital, Bozeman
- Saint James Community Hospital and Cancer Treatment Center, Butte
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 11. ruj 2025. · NCT03678025Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.